Relapsing/Refractory EGPA Amenable to Biologics

(MedPage Today) -- Study Authors: Alice Canzian, Nils Venhoff, et al.Target Audience and Goal Statement: Rheumatologists, pulmonologists, nephrologists, cardiologists, otolaryngologistsThe goal of this study was to examine the efficacy and...